Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HIV prevention largely due to barriers within our healthcare system. This research will consider the perspectives of women who inject drugs, healthcare providers, and clinic leadership to improve the way primary care and reproductive health clinics deliver PrEP to women who inject drugs, thereby reducing new HIV infections in this population.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of clinics enrolled that complete the intervention
Timeframe: 6 months
Number of intervention sessions completed by site champions
Timeframe: 6 months
Proportion of providers who engage in Practice Facilitation training sessions
Timeframe: 6 months
Proportion of providers who screen women who inject drugs for PrEP eligibility
Timeframe: 6 months
Proportion of providers who write a PrEP prescription to women who inject drugs
Timeframe: 6 months